We don't know whether the most recent response to this request contains information or not – if you are Sarai Keestra please sign in and let everyone know.

UAEM - Licensing and patenting practices of UK research institutions 2019-2020

Sarai Keestra made this Freedom of Information request to London School of Hygiene and Tropical Medicine

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

We're waiting for Sarai Keestra to read a recent response and update the status.

Dear London School of Hygiene and Tropical Medicine,

We have previously sent FOI requests asking for information about the licensing practices of UK universities. This was concerning the time period 18th October 2018 to 18th October 2019. We are now looking to update the information for the following year, 19th October 2019 to 19th October 2020.

The updated request is listed below:
For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions
Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...
Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:
Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the period 19th October 2019 to 19th October 2020 AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the period 19th October 2019 to 19th October 2020, listed by patent family, indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event, or at another university
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other
❏ None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the period 19th October 2019 to 19th October 2020 to improve access to the technologies they license in low-and middle-income settings?

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

LSHTM Servicedesk, London School of Hygiene and Tropical Medicine

LSHTM ServiceDesk
London School of Hygiene & Tropical Medicine

Re: Freedom of Information request - UAEM - Licensing and patenting
practices of UK

Thank you for your request for information under the Freedom of
Information Act.  We will process your request as soon as possible and
will respond within 20 working days.

Information on how we process Freedom of Information requests is available
on the LSHTM website at :
[1]https://www.lshtm.ac.uk/aboutus/organisa...

We may need to contact you again if we require further information from
you in order to process your request.
 
We will also contact you as soon as possible if we determine that a fee
will be payable for reprographics costs (such as photocopying or printing)
or postage costs associated with your request.

Please do not hesitate to contact us by reply to this email if you have
any questions relating to your request.

Regards,
Freedom of Information team

--------------------------------------------------------------------------

London School of Hygiene & Tropical Medicine
Keppel Street, London WC1E 7HT UK |  [2]www.lshtm.ac.uk

 

References

Visible links
1. https://www.lshtm.ac.uk/aboutus/organisa...
2. http://www.lshtm.ac.uk/

LSHTM Servicedesk, London School of Hygiene and Tropical Medicine

LSHTM ServiceDesk
London School of Hygiene & Tropical Medicine

Hi

Your request Freedom of Information request - UAEM - Licensing and
patenting practices of UK has now been completed.

Dear Sarai,

Thank you for your freedom of information request, and subsequent follow
up. I apologise for our delay- I’m afraid, it has been necessary for us to
liaise closely with other departments across LSHTM in order to process
it.  As I am sure you will appreciate, during the current global pandemic,
it has been necessary for LSHTM to adapt its operational approach in
various respects and to prioritise certain areas of its operations during
this extraordinary period. This, combined with the fact that the majority
of our sites are currently closed and the vast majority of our staff are
currently working from home, has had an inevitable impact on the timeframe
for dealing with and/or responding to Freedom of Information requests in a
small number of cases.

I write with a response to your request:

Q1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document.
LSHTM has an [1]IP Policy in place which provides a framework and guidance
for the effective identification, protection and translation of LSHTM
intellectual property (IP) to ensure that LSHTM’s research activities
deliver societal impact and patient benefit in an ethical and socially
responsible manner.

Q2. Please provide an Excel spreadsheet with headings as displayed below
with all the health technologies LICENSED by the university in the period
19th October 2019 to 19th October 2020 AND specify which countries they
were licensed in AND specify whether they are exclusive or non-exclusive
licenses.
Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

 London School of Hygiene & Tropical Medicine had only   one licence  in
the period 19th October 2019 to 19th October 2020 . Please see details
below:

Health Technology licensed:  Mosquito attractants
Country of Licensing: worldwide
Type of license: exclusive

Please note that licences are often granted as part of Research projects
to collaborators, subcontractors and funders as it is not specific
technologies but “arising IP” defined before it is generated, at the
inception of the project.

Q3. Please provide a list of patents granted to your organization in the
period 19th October 2019 to 19th October 2020, listed by patent family,
indicating countries/regions in which the patent has been granted.

Patent information available at [2]Espacenet.

Q4. In the period 19th October 2019 to 19th October 2020, has the
university shared its best practices for promoting access to medicines
through non-exclusive licensing by carrying out any of the following
activities?
❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing
practices
❏ Formally presented on access licensing practices at an academic or
professional event, or at another university
❏ Informally shared or discussed access licensing practices with
administrators at other universities
Yes
❏ Other
❏ None

(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in
the period 19th October 2019 to 19th October 2020 to improve access to the
technologies they license in low-and middle-income settings?
LSHTM has joined WIPO Re:Search which connects partners who could make
their IP available free of charge for development of technologies for the
poorest developing countries. WIPO Re:Search supports early-stage research
and development (R&D) in the fight against neglected tropical diseases
(NTDs), malaria, and tuberculosis. 
The LSHTM IP Policy is currently being updated and will include specific
language addressing the issue of access in the developing world.

Some standard sections follow on the re-use of the information which has
been supplied to you, and your right to appeal if you are dissatisfied
with our handling of your request.

Re-use of the information supplied to you

The copyright of any information which has been supplied to you will be
owned by LSHTM unless otherwise indicated. The supply of information under
the Freedom of Information Act or the Environmental Information
Regulations does not give the person or organisation who receives it an
automatic right to re-use the information in a way which would infringe
copyright, for example, by making multiple copies, publishing and issuing
copies to the public.
Brief extracts of any material which is supplied to you may be reproduced
under the fair dealing provisions of the Copyright, Designs and Patents
Act 1988 (sections 29 and 30) for research or private study for
non-commercial purposes, criticism, review or news reporting. More
extensive re-use must only be carried out with prior written permission
from LSHTM.
Enquiries about the re-use of material should be directed to the Archivist
& Records Manager (email: [email address]).

Your right to appeal

If you are dissatisfied with the handling of your Freedom of Information
or Environmental Information request, you are encouraged to contact
[London School of Hygiene and Tropical Medicine request email] in the first instance, to determine if your concerns can
be resolved informally. This may lead to a quicker resolution of your
complaint than a formal appeal.

If you remain dissatisfied, you can ask for an internal review of LSHTM's
handling of your request. Appeals should be submitted promptly, and within
12 months of the School's response to your request. If you wish to
complain about a request to which we responded more than 12 months ago,
you should contact the Information Commissioner (see below), as LSHTM will
not process your appeal.
Appeals should be sent in writing to the Secretary at the following
address. You should state as fully as possible why you think your request
was not dealt with in accordance with the Freedom of Information Act or
the Environmental Information Regulations, and the remedy which you are
seeking from the School:

Secretary
London School of Hygiene & Tropical Medicine
Keppel Street
London
WC1E 7HT
Email: [London School of Hygiene and Tropical Medicine request email]

The Secretary will assign your appeal to a review committee, and will
acknowledge receipt of your appeal. The chair of the review committee will
respond to your appeal within 40 working days of its receipt by the
Secretary. If the review committee decides that information should be
released to you, the information will be provided to you as soon as is
practically possible.

If you are dissatisfied with LSHTM's response to your appeal, you can
apply to the Information Commissioner for a decision on whether your
request has been dealt with in accordance with the requirements of the
Freedom of Information Act or the Environmental Information Regulations.
The Commissioner will normally require you to have gone through our
internal appeal process first before he considers your appeal. If the
Commissioner finds in your favour, the Commissioner can require LSHTM to
release the information to you. The Commissioner can be contacted at the
following address:

Information Commissioner
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
United Kingdom

Further information about your right to appeal to the Information
Commissioner is available on the Commissioner's website
(http://www.ico.gov.uk/).

Please do not hesitate to contact [London School of Hygiene and Tropical Medicine request email] if you have any
questions relating to our response to your request.

Yours sincerely

Freedom of Information Team

Did you know you can provide feedback about this call? School staff and
students can [3]click here to review or rate their call under My Requests
in the [4]ServiceDesk Portal.

Alternatively, you can reply to this email or phone us quoting reference
2011-1716

LSHTM ServiceDesk
[5]servicedesk.lshtm.ac.uk
+44 (0)20 7927 2186

--------------------------------------------------------------------------

London School of Hygiene & Tropical Medicine
Keppel Street, London WC1E 7HT UK | +44 (0)20 7636 8636 |
[6]www.lshtm.ac.uk

References

Visible links
1. https://www.lshtm.ac.uk/sites/default/fi...
2. https://worldwide.espacenet.com/patent/
3. http://lshtm.topdesk.net/tas/public/cont...
4. http://servicedesk.lshtm.ac.uk/
5. http://servicedesk.lshtm.ac.uk/
6. http://www.lshtm.ac.uk/

We don't know whether the most recent response to this request contains information or not – if you are Sarai Keestra please sign in and let everyone know.